Radio and PodcastRadio and PodcastLive Radio & Podcasts
Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer? artwork
Science & Medicine

Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?

GRACEcast by Howard (Jack) West, MD

Jul 22, 201402:27Science & Medicine

Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.

Related Episodes

Continue listening to more episodes from GRACEcast.

Management of Rare Kidney Tumors

Jul 29, 2014 - 01:55

What puts you at risk for inherited kidney cancer? Dr. Nizar Tannir discusses the signs doctors look for...